Gene Therapy Trial Monitors Must Not Report To Sponsor-Investigators - Cmte
Executive Summary
Clinical monitors for gene therapy trials must be independent from sponsor-investigators, FDA's Biological Response Modifiers Advisory Committee concluded April 5.